BISPECIFIC TRIGGER MOLECULES RECOGNIZING LYMPHOCYTE ANTIGEN CD2 AND TUMOR-SPECIFIC ANTIGENS
展开▼
机译:双特异性触发分子,可识别淋巴细胞抗原CD2和肿瘤特异性抗原。
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to novel and highly effective bispecific antibody fragments which recognize lymphocyte CD2 antigen and any variable tumor antigen. Moreover, the invention relates to two new monoclonal antibodies termed AICD2.M1 and AICD2.M2. A combination of these antibodies, whereby at least one of them is a bispecfic antibody fragment, can be used successfully in tumor therapy and diagnostics.
展开▼